Penelope Hallett
Affiliations: | 2002-2006 | Neurology | Harvard Medical School, Boston, MA, United States |
Google:
"Penelope Hallett"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rocha EM, Smith GA, Park E, et al. (2015) Progressive decline of glucocerebrosidase in aging and Parkinson's disease. Annals of Clinical and Translational Neurology. 2: 433-8 |
| Smith GA, Rocha EM, Rooney T, et al. (2015) A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C). Plos One. 10: e0121072 |
| Silverdale MA, Kobylecki C, Hallett PJ, et al. (2010) Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate. Synapse (New York, N.Y.). 64: 177-80 |
| Zhang J, Xu TX, Hallett PJ, et al. (2009) PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 2948-60 |
| Hallett PJ, Collins TL, Standaert DG, et al. (2008) Biochemical fractionation of brain tissue for studies of receptor distribution and trafficking. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 1.16 |
| Nicholas AP, Lubin FD, Hallett PJ, et al. (2008) Striatal histone modifications in models of levodopa-induced dyskinesia. Journal of Neurochemistry. 106: 486-94 |
| Mendez I, Viñuela A, Astradsson A, et al. (2008) Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nature Medicine. 14: 507-9 |
| Zhang J, Vinuela A, Neely MH, et al. (2007) Inhibition of the dopamine D1 receptor signaling by PSD-95. The Journal of Biological Chemistry. 282: 15778-89 |
| Hallett PJ, Brotchie JM. (2007) Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 28-40 |
| Hallett PJ, Spoelgen R, Hyman BT, et al. (2006) Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 4690-700 |